Cardiol Therapeutics Inc.

CRDL chart

Cardiol Therapeutics Inc. news

• What Does Cardiol Therapeutics (TSX:CRDL) Funding Mean for Biotech?

  Kalkine Media · Nov 5, 3:44 PM EST

• Cardiol Therapeutics Inc. [TSX:CRDL]: The Catalyst Driving Fresh Investor Attention Today

  kalkine.ca · Nov 5, 11:51 AM EST

• Cardiol Therapeutics launches USD 75m ATM offering after MAVERIC trial expands enrollment

  AllSci · Nov 5, 6:36 AM EST

• Cardiol Therapeutics (TSX:CRDL) Launches At-The-Market Program With Jefferies

  Kalkine Media · Nov 4, 2:36 PM EST

• Cardiol Therapeutics (CRDL) Launches $75M ATM Offering with Jeff

  GuruFocus · Nov 3, 7:25 PM EST

• Cardiol Therapeutics establishes $75M equity offering program By Investing.com

  Investing.com Nigeria · Nov 3, 5:59 PM EST

• Cardiol Therapeutics Sets Up $75 Million Share-Sale Program

  www.tokenpost.com · Nov 3, 5:30 PM EST

• No shares must be sold under Cardiol Therapeutics (Nasdaq: CRDL)'s new stock offering.

  Stock Titan · Nov 3, 5:17 PM EST

• Nasdaq, not TSX, is the venue for Cardiol Therapeutics (CRDL)'s at-the-market share sales.

  Stock Titan · Nov 3, 5:17 PM EST

• Cardiol Therapeutics drops after launching a $75M ATM offering

  TradingView · Nov 3, 5:17 PM EST

• Cardiol Therapeutics Inc. (CRDL) May Sell Up to $75M in ATM Offering

  TradingView · Nov 3, 5:03 PM EST

• Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC

  Yahoo Finance · Nov 3, 5:00 PM EST

Cardiol Therapeutics Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KFORM 6-K2026-11-03
• 6-KFORM 6-K2026-11-03
• 6-KFORM 6-K2026-09-23
• 6-KFORM 6-K2026-09-16
• 6-KFORM 6-K2026-09-15
• 6-KFORM 6-K2026-09-11
• 6-KFORM 6-K2026-09-10
• 6-KFORM 6-K2026-09-09
• 6-KFORM 6-K2026-08-12
• 6-KFORM 6-K2026-08-05
• 6-KFORM 6-K2026-07-14
• 6-KFORM 6-K2026-07-09

About Cardiol Therapeutics Inc.

Ticker

CRDL (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

Oakville, Ontario, Canada

Incorporated in

Ontario, Canada

Fiscal year end

December 31

SEC CIK

1702123

Frequently asked questions